GLAXOSMITHKLINE PHARMACEUTICALS LTD.
| Report Date | Research house | Description | Reco | At Price | Target Price | UpSide
/DownSide | Download |
|
7-Feb-22
|
Motilal Oswal
|
Product mix drives profitability
|
Neutral
|
1580
|
1630
|
3.16
|
|
|
22-May-17
|
Angel Broking
|
GlaxoSmithKline Pharmaceuticals (GSK) posted better than expected..
|
Neutral
|
2428
|
|
|
|
|
15-Feb-17
|
Angel Broking
|
For 3QFY2017 Glaxo Pharmaceuticals (GSK) posted results lower tha..
|
Neutral
|
2683
|
0.00
|
-100
|
|
|
14-Feb-17
|
Motilal Oswal
|
3QFY17 sales declined 5.5% YoY to INR6.9b (14% below estimates).
|
Neutral
|
2684
|
2700
|
0.6
|
|
|
9-Nov-16
|
Angel Broking
|
For 2QFY2017, sales stood at Rs783cr vs. Rs700cr expected and vs...
|
Neutral
|
2719
|
0.00
|
-100
|
|
asdsa
Upcoming Events and Recent Updates
No Recent Updates.